Clinical Scorecard: A Prospective Analysis of Clinical, Social, and Treatment Factors Influencing Quality of Life in Romanian Males with Co-occurring Schizophrenia and Alcohol Use Disorder

At a Glance

Key Highlights

• Higher quality of life (QoL) associated with greater self-care capacity and social support.
• Need for antipsychotic treatment linked to lower QoL.
• Anti-craving medication receipt predicted better QoL at follow-up.
• Negative and general psychopathology correlated with poorer QoL.
• Alcohol use severity not independently associated with QoL.

Guideline-Based Recommendations

Diagnosis

• Utilize the Positive and Negative Syndrome Scale (PANSS) for assessing psychopathological symptoms.
• Employ the Michigan Alcohol Screening Test (MAST) for screening alcohol use severity.

Management

• Implement integrated addiction treatment alongside psychiatric care.
• Focus on enhancing self-care and social functioning.

Monitoring & Follow-up

• Regularly assess quality of life using the WHOQoL–BREF.
• Monitor treatment response and psychosocial needs.

Risks

• Higher relapse rates and increased healthcare burden associated with dual diagnosis.
• Potential for poorer functioning and lower QoL due to alcohol use.

Patient & Prescribing Data

Males with schizophrenia and comorbid AUD.

Naltrexone and acamprosate recommended as first-line treatments for AUD.

Clinical Best Practices

• Adopt a multidimensional, recovery-oriented approach for dual diagnosis management.
• Incorporate family-focused and community-based interventions.

Related Resources & Content

• World Health Organization Quality of Life–BREF
• Positive and Negative Syndrome Scale
• Michigan Alcohol Screening Test